David Stirling is the founder of BioTheryX. BioTheryX has raised $127M in total funding. Based in San Diego, California.
David Stirling is the Co-founder and Chair of the Board at BioTheryX, a clinical-stage biopharmaceutical company focused on targeted protein degradation therapies for cancer and immunological diseases. He previously served as the Founder and CEO of BioTheryX and is also Chair of the Board at NovoMedix. Stirling is recognized as a scientist and entrepreneur in the biotechnology sector.
Full founder directory · Investor directory · Company funding database · Fundraising library